You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
創美藥業(02289.HK)中期純利3087萬元 同比減少27.02%
格隆匯 08-23 18:14

格隆匯8月23日丨創美藥業(02289.HK)公佈,截至2020年6月30日止6個月,公司營業收入18.6億元人民幣,同比增長8.94%;歸屬於母公司股東的淨利潤3087萬元,同比減少27.02%;每股收益0.2859元。

收入增加主要是由於新型冠狀病毒疫情爆發,各類防疫產品銷量增加。

毛利率由2019年6月30日止六個月的8.00%下降至截至2020年6月30日止六個月的6.57%,主要是由於各類防疫產品出廠價格急速上升,集團響應國家號召維持疫情藥品及物資價格穩定,疫情相關藥品和物資毛利率下降。

截至2020年6月30日,我們的分銷網絡覆蓋8,374名客户,其中564名為分銷商,5,602名為零售藥店,2,208名為醫院、診所、衞生站及其他。較上年度同期,客户數增加1,274名,其中分銷商減少13名,零售藥店增加841名,醫院、診所、衞生站及其他增加446名。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account